24.44
+1.96(+8.72%)
Currency In USD
| Previous Close | 22.48 |
| Open | 22.68 |
| Day High | 24.45 |
| Day Low | 22.5 |
| 52-Week High | 29.94 |
| 52-Week Low | 9.71 |
| Volume | 2.11M |
| Average Volume | 2.86M |
| Market Cap | 2.1B |
| PE | -13.43 |
| EPS | -1.82 |
| Moving Average 50 Days | 25.11 |
| Moving Average 200 Days | 17.53 |
| Change | 1.96 |
If you invested $1000 in Liquidia Corporation (LQDA) since IPO date, it would be worth $2,201.8 as of October 21, 2025 at a share price of $24.44. Whereas If you bought $1000 worth of Liquidia Corporation (LQDA) shares 5 years ago, it would be worth $5,860.91 as of October 21, 2025 at a share price of $24.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
GlobeNewswire Inc.
Oct 07, 2025 10:30 AM GMT
MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Dev
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting
GlobeNewswire Inc.
Sep 29, 2025 12:30 PM GMT
MORRISVILLE, N.C., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two ora
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
GlobeNewswire Inc.
Sep 11, 2025 12:30 PM GMT
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present fou